Q3 2024 Earnings Call Transcript November 7, 2024 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.17. Operator: Greetings, and welcome to the ...

Clearpoint Neuro, Inc. ( (CLPT) ) has released its Q3 earnings. Here is a breakdown of the information Clearpoint Neuro, Inc. presented to its ...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, ...

Longitudinal survey data from Mexico suggested that a so-called weekend warrior physical activity pattern was associated with ...

Lake Street raised the firm’s price target on ClearPoint Neuro (CLPT) to $17 from $15 and keeps a Buy rating on the shares. Q3 outperformance was driven by another quarter of broad-business strength, ...

T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases, announced today the appointment of Dr. Jeffrey Cummings, MD, ScD as Chair ...

ClearPoint Neuro develops and commercializes platforms for performing minimally invasive surgical procedures in the brain.

Reported quarterly revenue of $8.1 million, a 41% year-over-year increase; Accelerated growth of SmartFrame OR ™ platform and ClearPoint Prism ® Laser Therapy System, contributing to record navigation ...

Written by Cris Franco Why are so many of the neuro-diverse community drawn to the arts? Perhaps it’s because their unique ...

David Harrington, CEO of Centre for Neuro Skills, discusses the need for specialized treatment for brain injury patients with ...

Finding the right remedy can feel daunting in a world increasingly dominated by stress and sleepless nights. Sleep is a vital component of our overall health, affecting everything from mood and ...